Comments
Loading...

Werewolf Therapeutics Analyst Ratings

HOWLNASDAQ
Logo brought to you by Benzinga Data
$0.7332
0.035.00%
Pre-Market: Apr 4, 4:09 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$17.00
Lowest Price Target1
$4.00
Consensus Price Target1
$10.38

Werewolf Therapeutics Analyst Ratings and Price Targets | NASDAQ:HOWL | Benzinga

Werewolf Therapeutics Inc has a consensus price target of $10.38 based on the ratings of 6 analysts. The high is $17 issued by SVB Leerink on May 11, 2022. The low is $4 issued by JMP Securities on January 14, 2025. The 3 most-recent analyst ratings were released by Wedbush, HC Wainwright & Co., and JMP Securities on March 12, 2025, March 12, 2025, and January 14, 2025, respectively. With an average price target of $9 between Wedbush, HC Wainwright & Co., and JMP Securities, there's an implied 1127.50% upside for Werewolf Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov 24
0
0
0
0
Jan
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wedbush
HC Wainwright & Co.
JMP Securities
EF Hutton
B of A Securities

1calculated from analyst ratings

Analyst Ratings for Werewolf Therapeutics

Buy NowGet Alert
03/12/2025Buy Now991.11%Wedbush
Robert Driscoll43%
$8 → $8ReiteratesOutperform → OutperformGet Alert
03/12/2025Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
01/14/2025Buy Now445.55%JMP Securities
Reni Benjamin45%
$12 → $4MaintainsMarket OutperformGet Alert
11/19/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
07/02/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
06/26/2024Buy Now1536.66%JMP Securities
Reni Benjamin45%
$12 → $12ReiteratesMarket Outperform → Market OutperformGet Alert
06/26/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
06/04/2024Buy Now1536.66%JMP Securities
Reni Benjamin45%
$12 → $12ReiteratesMarket Outperform → Market OutperformGet Alert
06/03/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
05/06/2024Buy Now1536.66%JMP Securities
Reni Benjamin45%
$12 → $12ReiteratesMarket Outperform → Market OutperformGet Alert
05/06/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15ReiteratesBuy → BuyGet Alert
04/03/2024Buy Now1536.66%JMP Securities
Reni Benjamin45%
→ $12Initiates → Market OutperformGet Alert
03/07/2024Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$15 → $15MaintainsBuyGet Alert
11/15/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
10/31/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
09/19/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
09/15/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
08/24/2023Buy Now1127.5%Wedbush
Robert Driscoll43%
→ $9Initiates → OutperformGet Alert
08/10/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
05/25/2023Buy Now1032.02%EF Hutton
Michael King44%
→ $8.3Assumes → BuyGet Alert
05/12/2023Buy Now1263.88%B of A Securities
Jason Zemansky74%
$9 → $10MaintainsBuyGet Alert
05/11/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
→ $15ReiteratesBuy → BuyGet Alert
03/24/2023Buy Now1032.02%EF Hutton
Michael King44%
→ $8.3Reiterates → BuyGet Alert
03/23/2023Buy Now1127.5%B of A Securities
Jason Zemansky74%
→ $9ReiteratesBuy → BuyGet Alert
03/23/2023Buy Now1945.83%HC Wainwright & Co.
Andres Maldonado40%
$20 → $15Reiterates → BuyGet Alert
02/27/2023Buy Now1032.02%EF Hutton
Michael King44%
→ $8.3Reiterates → BuyGet Alert
02/17/2023Buy Now1032.02%EF Hutton
Michael King44%
→ $8.3Reiterates → BuyGet Alert
01/30/2023Buy Now991.11%B of A Securities
Jason Zemansky74%
$9 → $8MaintainsBuyGet Alert
12/05/2022Buy Now1032.02%EF Hutton
Michael King44%
→ $8.3Initiates → BuyGet Alert
06/02/2022Buy Now2627.77%HC Wainwright & Co.
Andres Maldonado40%
→ $20Assumes → BuyGet Alert
05/11/2022Buy Now2218.6%SVB Leerink
Daina Graybosch43%
$18 → $17MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Werewolf Therapeutics (HOWL) stock?

A

The latest price target for Werewolf Therapeutics (NASDAQ:HOWL) was reported by Wedbush on March 12, 2025. The analyst firm set a price target for $8.00 expecting HOWL to rise to within 12 months (a possible 991.11% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ:HOWL) was provided by Wedbush, and Werewolf Therapeutics reiterated their outperform rating.

Q

When was the last upgrade for Werewolf Therapeutics (HOWL)?

A

There is no last upgrade for Werewolf Therapeutics

Q

When was the last downgrade for Werewolf Therapeutics (HOWL)?

A

There is no last downgrade for Werewolf Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $8.00 to $8.00. The current price Werewolf Therapeutics (HOWL) is trading at is $0.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch